A spokesperson said the company was in the process of investigating the allegations: “While we are confident in the veracity of our application, we take all accusations seriously."

Nearly four years after Arts & Crafts began accumulating dilapidated and underutilized properties in a once-industrial area, its efforts are being validated.

With the help of firemen, the group crawled through the elevator shaft to escape. The breakdown was caused by a tripped electrical breaker, and the building's owner says the problem is now fixed.

In its latest — and likely final — iteration, the Broad and Spruce Street tower to be known as Arthaus will stand 47 stories and host 108 condos.

In Bob Burch’s ideal world, the acreage would stay mostly preserved, he said, with 31 spectacular cottages forming a residential village in sync with the French Normandy style of the 14,000-square-foot, 20-room manor home, once owned by an heir to Campbell Soup.

Kenneth Parker lived and worked in the Reading Co. Grain Elevator building in Fairmount in the 1970s and 1980s, when he was having an outsized impact on corporate life in Philadelphia as the city’s most prolific designer of office space.

The proposal is a response to a growing demand within Philadelphia’s flourishing gene- and cell-therapy industries for specialized lab space.

Philadelphia Finance Director Rob Dubow testified Tuesday, defending the city's 2018 reassessment that raised $118 million in additional revenue for the city and school district.

owners of 700 commercial properties are attempting to prove to a judge that Philadelphia illegally targeted them in a 2018 revaluation that significantly increased their tax bills.

The secluded industrial ruin is slated for conversion into the centerpiece of a new public park.

Developers say the opening of The Kelly apartments marked the first wave of revitalization for a sleepy area off City Avenue they’ve coined “NoBA.” Residents are less optimistic about the rebirth of City Avenue as a whole.

Morgan, Lewis & Bockius LLP says it is in “active negotiations" to occupy a building at the 23rd and Market Street site.

The San Carlos, Calif.-based firm joins others selecting Philadelphia to develop and manufacture high-tech therapies for what have been mostly irremediable conditions.